Bictegravir/emtricitabine/tenofovir alafenamide plus doravirine in highly treatment-experienced men with multidrug-resistant HIVInformed Consent Document • December 20th, 2023Contract TypeInformed Consent DocumentFiledDecember 20th, 2023